Japp A, Meng W, Rosenfeld A, Perry D, Thirawatananond P, Bacher R, et al. TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes. Cell. 2021;184:827-839.e14 pubmed publisher

Kunishita Y, Yoshimi R, Kamiyama R, Kishimoto D, Yoshida K, Hashimoto E, et al. TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis. Front Immunol. 2020;11:98 pubmed publisher

Liu T, Li B, Jiang Y, Zheng C, Zhang L, Wang Y. Screening and identification of novel specific markers of breast cancer stem cells. Oncol Lett. 2019;18:2262-2269 pubmed publisher

Matossian M, Burks H, Elliott S, Hoang V, Bowles A, Sabol R, et al. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. BMC Cancer. 2019;19:205 pubmed publisher

Fu J, Zuber J, Martinez M, Shonts B, Obradovic A, Wang H, et al. Human Intestinal Allografts Contain Functional Hematopoietic Stem and Progenitor Cells that Are Maintained by a Circulating Pool. Cell Stem Cell. 2019;24:227-239.e8 pubmed publisher

Hao J, Zhang Y, Yan X, Yan F, Sun Y, Zeng J, et al. Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development. Cell Metab. 2018;28:689-705.e5 pubmed publisher

Shah D, Wyatt D, Baker A, Simms P, Peiffer D, Fernandez M, et al. Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1. Clin Cancer Res. 2018;24:4566-4578 pubmed publisher

Nakazawa Y, Taniyama Y, Sanada F, Morishita R, Nakamori S, Morimoto K, et al. Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer. Sci Rep. 2018;8:4013 pubmed publisher

Lo P, Yao Y, Lee J, Zhang Y, Huang W, KANE M, et al. LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer. elife. 2018;7: pubmed publisher

Domínguez Gómez G, Chavez Blanco A, Medina Franco J, Saldivar Gonzalez F, Flores Torrontegui Y, Juárez M, et al. Ivermectin as an inhibitor of cancer stem‑like cells. Mol Med Rep. 2018;17:3397-3403 pubmed publisher

Junk D, Bryson B, Smigiel J, Parameswaran N, Bartel C, Jackson M. Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling. Oncogene. 2017;36:4001-4013 pubmed publisher

Lubaki N, Younan P, Santos R, Meyer M, Iampietro M, Koup R, et al. The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses. PLoS Pathog. 2016;12:e1006031 pubmed publisher

Singh S, Zeng X, Zhao J, Liu Y, Hou G, Liu H, et al. The lipolysis pathway sustains normal and transformed stem cells in adult Drosophila. Nature. 2016;538:109-113 pubmed publisher

Lima J, Martins C, Nunes G, Sousa M, Branco J, Borrego L. Impact of Labor on Peripheral Blood Maternal T-Cell Subsets and on Regulatory T and B Cells. Reprod Sci. 2017;24:276-284 pubmed publisher

Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George G, Hong D, et al. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015;5:17533 pubmed publisher

McClellan S, Slamecka J, Howze P, Thompson L, Finan M, Rocconi R, et al. mRNA detection in living cells: A next generation cancer stem cell identification technique. Methods. 2015;82:47-54 pubmed publisher

Glinka Y, Mohammed N, Subramaniam V, Jothy S, Prud homme G. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-?B activation and tumor sphere formation. Biochem Biophys Res Commun. 2012;425:775-80 pubmed publisher

Prud homme G, Glinka Y, Toulina A, Ace O, Subramaniam V, Jothy S. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist. PLoS ONE. 2010;5:e13831 pubmed publisher